NASDAQ:GBNH - Greenbrook TMS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $18.85
  • Forecasted Upside: 371.25 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$4.00
▲ +0.08 (2.04%)

This chart shows the closing price for GBNH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Greenbrook TMS Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GBNH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GBNH

Analyst Price Target is $18.85
▲ +371.25% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Greenbrook TMS in the last 3 months. The average price target is $18.85, with a high forecast of $23.75 and a low forecast of $16.00. The average price target represents a 371.25% upside from the last price of $4.00.

This chart shows the closing price for GBNH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 contributing investment analysts is to buy stock in Greenbrook TMS.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/25/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/24/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/22/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/21/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/20/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/23/2021DesjardinsLower Price TargetBuyC$20.00 ➝ C$18.50Low
11/11/2021Stifel NicolausLower Price TargetBuyC$22.00 ➝ C$19.00High
11/11/2021Clarus SecuritiesLower Price TargetAverage ➝ BuyC$26.00 ➝ C$23.75High
11/11/2021DesjardinsReiterated RatingBuyC$20.00High
10/5/2021Lake Street CapitalInitiated CoverageBuy$17.00High
10/5/2021Bloom BurtonReiterated RatingBuy$16.00Medium
9/30/2021Clarus SecuritiesReiterated RatingSpeculative BuyMedium
7/8/2021DesjardinsInitiated CoverageBuyHigh
4/9/2021Bloom BurtonReiterated RatingBuy$16.00Low
(Data available from 1/20/2017 forward)

News Sentiment Rating

0.18 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2021
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/21/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/20/2022

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Greenbrook TMS logo
Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $4.00
Low: $4.00
High: $4.13

50 Day Range

MA: $5.13
Low: $3.20
High: $7.16

52 Week Range

Now: $4.00
Low: $3.00
High: $17.55

Volume

1,734 shs

Average Volume

37,744 shs

Market Capitalization

$71.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Greenbrook TMS?

The following sell-side analysts have issued reports on Greenbrook TMS in the last twelve months: Bloom Burton, Clarus Securities, Desjardins, Lake Street Capital, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for GBNH.

What is the current price target for Greenbrook TMS?

5 Wall Street analysts have set twelve-month price targets for Greenbrook TMS in the last year. Their average twelve-month price target is $18.85, suggesting a possible upside of 371.3%. Clarus Securities has the highest price target set, predicting GBNH will reach $23.75 in the next twelve months. Bloom Burton has the lowest price target set, forecasting a price of $16.00 for Greenbrook TMS in the next year.
View the latest price targets for GBNH.

What is the current consensus analyst rating for Greenbrook TMS?

Greenbrook TMS currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GBNH will outperform the market and that investors should add to their positions of Greenbrook TMS.
View the latest ratings for GBNH.

How do I contact Greenbrook TMS's investor relations team?

Greenbrook TMS's physical mailing address is 890 YONGE STREET 7TH FLOOR, TORONTO A6, M4W 3P4. The company's listed phone number is (416) 915-9100 and its investor relations email address is [email protected] The official website for Greenbrook TMS is www.greenbrooktms.com.